LORBRENA: payments to doctors
Payments that named LORBRENA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.3M
- Providers
- 8,460
- Transactions
- 32,808
- Average per transaction
- $101
The per-transaction average — $101 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,460 providers the average total is $391, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $2,925,413 | 88.5% |
| Array Biopharma Inc | $365,234 | 11.1% |
| Whitehall International Inc | $7,700 | 0.2% |
| PBG Puerto RICO LLC | $4,884 | 0.1% |
| Pfizer Pharmaceuticals LLC | $930 | 0.0% |
| Pfizer ZONA Franca, S.A. | $535 | 0.0% |
| Medivation Services LLC | $130 | 0.0% |